Keratinizing Squamous Cell Carcinoma of the Nasopharynx

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma [Phase 1]

  A Phase 1 trial evaluating vorinostat with azacitidine in adults with nasal-type extranodal NK/T-cell lymphoma or recurrent nasopharyngeal c…